Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

propensity score matching

  • Open Access
    D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma
    LIMING WANG, BOLUN SONG, YINGGANG CHEN and YASUMITSU HIRANO
    In Vivo March 2024, 38 (2) 807-818; DOI: https://doi.org/10.21873/invivo.13505
  • Open Access
    Survey of Smokers Among Workers at One Facility: A Cross-sectional Study With Propensity Score Matching
    YUGA KOMAKI, MIHARU USHIKAI, SHUJI KANMURA and MASAHISA HORIUCHI
    In Vivo July 2023, 37 (4) 1873-1879; DOI: https://doi.org/10.21873/invivo.13279
  • You have access
    Prognostic Utility of Apical Lymph Node Metastasis in Patients With Left-sided Colorectal Cancer
    LIMING WANG, YASUMITSU HIRANO, GREGORY HENG, TOSHIMASA ISHII, HIROKA KONDO, KIYOKA HARA, NAO OBARA, MASAHIRO ASARI and SHIGEKI YAMAGUCHI
    In Vivo September 2020, 34 (5) 2981-2989; DOI: https://doi.org/10.21873/invivo.12129
  • You have access
    Bevacizumab as First-line Treatment for HER2-negative Advanced Breast Cancer: Paclitaxel plus Bevacizumab Versus Other Chemotherapy
    SHOGO NAKAMOTO, JUNICHIRO WATANABE, SHOICHIRO OHTANI, SATOSHI MORITA and MASAHIKO IKEDA
    In Vivo May 2020, 34 (3) 1377-1386; DOI: https://doi.org/10.21873/invivo.11917
In Vivo

© 2026 In Vivo

Powered by HighWire